GPCR and NVO Related Headlines
Go Back- Oral GLP-1 obesity drugs see rapid early adoption, Bernstein survey shows
- Wolfe: 'We're observing some reports of GLP-1 users refreshing their wardrobes as weight loss progresses'
- Leerink on Structure Therapeutics (GPCR): 'Oral GLP-1 Achieves Best-In-Class Weight Loss'
